본문 바로가기
KERD
논문KCI 등재

Toxicity Evaluation of a Non-Pain Pharmacopuncture Extract Using a Bacterial Reverse Mutation Test

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives: The objective of this study was to assess the genotoxicity of a no-pain pharmacopuncture (NPP) extract developed in 2022 using a bacterial reverse mutation assay, aiming to further substantiate the safety profile of NPP. Methods: The genotoxicity evaluation involved a bacterial reverse mutation assay to assess the mutagenic potential of NPP extracts with and without metabolic activation. Histidine-requiring Salmonella typhimurium strains (TA98, TA100, TA1535, and TA1537) and tryptophan-requiring Escherichia coli strains (WP2uvrA) were used in the assay. Results: The NPP extract did not induce a revertant colony count exceeding two times that of the negative control at any dose level in any of the tested strains, both with and without metabolic activation. Additionally, no growth inhibition or precipitation was observed in the presence of NPP. Conclusion: Based on the findings, it can be concluded that the NPP extract exhibited no mutagenic potential in the in vitro genotoxicity tests conducted.

Abstract

Objectives: The objective of this study was to assess the genotoxicity of a no-pain pharmacopuncture (NPP) extract developed in 2022 using a bacterial reverse mutation assay, aiming to further substantiate the safety profile of NPP. Methods: The genotoxicity evaluation involved a bacterial reverse mutation assay to assess the mutagenic potential of NPP extracts with and without metabolic activation. Histidine-requiring Salmonella typhimurium strains (TA98, TA100, TA1535, and TA1537) and tryptophan-requiring Escherichia coli strains (WP2uvrA) were used in the assay. Results: The NPP extract did not induce a revertant colony count exceeding two times that of the negative control at any dose level in any of the tested strains, both with and without metabolic activation. Additionally, no growth inhibition or precipitation was observed in the presence of NPP. Conclusion: Based on the findings, it can be concluded that the NPP extract exhibited no mutagenic potential in the in vitro genotoxicity tests conducted.

참고문헌 (35)

  1. Demma J, "Potential genotoxicity of plant extracts used in Ethiopian traditional medicine", J Ethnopharmacol, 122(1), pp.136~142 (2009)
  2. Kim HU, "A systems approach to traditional oriental medicine", Nat Biotechnol, 33(3), pp.264~268 (2015)
  3. Han T, "Single-and repeated-dose oral toxicity in rats and bacterial reverse mutation test of Morus alba L. extracts", Korean Soc Food Sci Nutr, 45(10), pp.1406~1413 (2016)
  4. Jeong JH, "A study on the significance of acupuncture and pharmacopuncture therapy for cold accumulation through a literature review on the historical development process in cold accumulation treatment", J Acupunct Res, 39(4), pp.267~274 (2022)
  5. Jung C, "Pharmacopuncture clinical guide" (2023), Koonja Publication
  6. Sung SH, "Current status of management on pharmacopuncture in Korea through introduction of an accreditation system", J Pharmacopuncture, 22(2), pp.75~82 (2019)
  7. Hwang JH, "In vivo genotoxicity evaluation of a no-pain pharmacopuncture extract using the micronucleus test", J Pharmacopuncture, 26(4), pp.366~372 (2023)
  8. Hwang JH, "Single-dose intramuscular toxicity test using no-pain pharmacopuncture in Sprague-Dawley rats", J Pharmacopuncture, 26(1), pp.86~93 (2023)
  9. Hwang JH, "A case report on a patient with plantar fasciitis using Korean medicine treatment focusing on Mutong pharmacopuncture", J Physiol Pathol Korean Med, 37(4), pp.87~91 (2023)
  10. Hwang JH, "Toxicity assessment of a no-pain pharmacopuncture extract using a standard battery of in vitro chromosome aberration tests", J Pharmacopuncture, 27(1), pp.38~46 (2024)
  11. Eisenberg DM, "Trends in alternative medicine use in the United States, 1990-1997 : results of a follow-up national survey", JAMA, 280(18), pp.1569~1575 (1998)
  12. Hayes AW, "Principles and methods of toxicology" (2001), Taylor & Francis
  13. Park HM, "Herbal toxicological effects on rats’fetus-focusing on Ojeoksan", Korean J Orient Prev Med Soc, 12(2), pp.27~35 (2008)
  14. Lee MY, "Genotoxicity evaluation of Guibi-Tang extract using an in vitro bacterial reverse mutation assay, chromosome aberration assay, and in vivo micronucleus test", BMC Complement Altern Med, 14, pp.215~ (2014)
  15. The Co-Textbook Publishing Committee of Korean Medicine College, "Herbology" (2004), Younglimsa
  16. Poivre M, "Toxicology of herbal products", pp.179~215 (2017), Springer
  17. Kim HJ, "A study on the effect of Erycibae Caulis and Corydalis Tuber pharmacopuncture on a mouse model with collagen induced rheumatoid arthritis", Acupuncture, 33(2), pp.21~34 (2016)
  18. Kim JH, "Recent trend of international guidelines for genotoxicity testing", Regul Res Food Drug Cosmet, 11(2), pp.201~209 (2016)
  19. Kirkland D, "Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity", Mutat Res, 584(1-2), pp.1~256 (2005)
  20. Aubrecht J, "Bioluminescent Salmonella reverse mutation assay : a screen for detecting mutagenicity with high throughput attributes", Mutagenesis, 22(5), pp.335~342 (2007)
  21. Levy DD, "Recommended criteria for the evaluation of bacterial mutagenicity data(Ames test)", Mutat Res Genet Toxicol Environ Mutagen, 848, pp.403074~ (2019)
  22. Verheyen GR, "Testing the mutagenicity potential of chemicals", J Genet Genome Res, 4(1), pp.029~ (2017)
  23. Tetsuo Sato, "Toxicology", pp.15~194 (2000), Donghwa Technology
  24. Ministry of Food and Drug Safety (MFDS), "Toxicity test standard of drugs", Ministry of Food and Drug Safety, ~ (2022)
  25. Ministry of Food and Drug Safety (MFDS), "Explanation standard of drugs", Ministry of Food and Drug Safety, ~ (2022)
  26. Wu G, "Ganoderma lucidum extract induces G1 cell cycle arrest, and apoptosis in human breast cancer cells", Am J Chin Med, 40(3), pp.631~642 (2012)
  27. Xiao HT, "Acetylcholinesterase inhibitors from Corydalis yanhusuo", Nat Prod Res, 25(15), pp.1418~1422 (2011)
  28. Zhou Q, "Two new quaternary protoberberine alkaloids from Corydalis yanhusuo", J Asian Nat Prod Res, 14(5), pp.476~481 (2012)
  29. Kobayashi K, "Augmentation of the pharmacological action of corydalis tuber by saussurea root in isolated mouse ileum", Yakugaku Zasshi, 121(8), pp.647~651 (2001)
  30. Xu XH, "Alkaloids from Rhizoma corydalis", J China Pharm Univ, 33(6), pp.483~486 (2002)
  31. Guo Z, "Levo-tetrahydropalmatine attenuates oxaliplatin-induced mechanical hyperalgesia in mice", Sci Rep, 4, pp.3905~ (2014)
  32. Liu YY, "Dopamine D1 and D2 receptors mediate analgesic and hypnotic effects of l-tetrahydropalmatine in a mouse neuropathic pain model", Psychopharmacology(Berl), 236(11), pp.3169~3182 (2019)
  33. Bai H, "Paeoniflorin ameliorates neuropathic pain-induced depression-like behaviors in mice by inhibiting hippocampal neuroinflammation activated via TLR4", NF-κB pathway, 2021, pp.25(3), 217~225
  34. Liu C, "The emerging role of quercetin in the treatment of chronic pain", Curr Neuropharmacol, 20(12), pp.2346~2353 (2022)
  35. Sun X, "Glycyrrhizin ameliorates inflammatory pain by inhibiting microglial activation-mediated inflammatory response via blockage of the HMGB1-TLR4-NF-kB pathway", Exp Cell Res, 369(1), pp.112~119 (2018)

관련 논문AI추천

이 간행물의 다른 논문 (11건)